177 related articles for article (PubMed ID: 38007383)
21. [Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas].
Vacchiano V; Seleme S; Daly AF; Beckers A; Valdés-Socin H
Medicina (B Aires); 2020; 80(2):181-184. PubMed ID: 32282328
[TBL] [Abstract][Full Text] [Related]
22. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
23. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
[TBL] [Abstract][Full Text] [Related]
25. Genetic factors in the development of pituitary adenomas.
Vandeva S; Tichomirowa MA; Zacharieva S; Daly AF; Beckers A
Endocr Dev; 2010; 17():121-133. PubMed ID: 19955762
[TBL] [Abstract][Full Text] [Related]
26. A review of multiomics platforms in pituitary adenoma pathogenesis.
Mouchtouris N; Smit RD; Piper K; Prashant G; Evans JJ; Karsy M
Front Biosci (Landmark Ed); 2022 Mar; 27(3):77. PubMed ID: 35345309
[TBL] [Abstract][Full Text] [Related]
27. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
Daly AF; Tichomirowa MA; Beckers A
Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
[TBL] [Abstract][Full Text] [Related]
28. Familial isolated pituitary adenomas: an emerging clinical entity.
Martucci F; Trivellin G; Korbonits M
J Endocrinol Invest; 2012 Dec; 35(11):1003-14. PubMed ID: 23310926
[TBL] [Abstract][Full Text] [Related]
29. Clinical and genetic aspects of familial isolated pituitary adenomas.
Vasilev V; Daly A; Naves L; Zacharieva S; Beckers A
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):37-41. PubMed ID: 22584704
[TBL] [Abstract][Full Text] [Related]
30. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
31. Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.
Hao S; Hong CS; Feng J; Yang C; Chittiboina P; Zhang J; Zhuang Z
J Neurosurg; 2016 Jun; 124(6):1562-7. PubMed ID: 26473790
[TBL] [Abstract][Full Text] [Related]
32. [Familial isolated pituitary adenoma syndrome].
Dénes J; Korbonits M; Hubina E; Kovács GL; Kovács L; Görömbey Z; Czirják S; Góth M
Orv Hetil; 2011 May; 152(18):722-30. PubMed ID: 21498161
[TBL] [Abstract][Full Text] [Related]
33. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
34. Genetics of pituitary adenomas.
Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
[TBL] [Abstract][Full Text] [Related]
35. Gigantism: X-linked acrogigantism and GPR101 mutations.
Iacovazzo D; Korbonits M
Growth Horm IGF Res; 2016; 30-31():64-69. PubMed ID: 27743704
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology and genetics of pituitary adenomas.
Daly AF; Tichomirowa MA; Beckers A
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):543-54. PubMed ID: 19945022
[TBL] [Abstract][Full Text] [Related]
37. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients.
Guaraldi F; Morandi L; Zoli M; Mazzatenta D; Righi A; Evangelisti S; Ambrosi F; Tonon C; Giannini C; Lloyd RV; Asioli S
Clin Endocrinol (Oxf); 2022 Dec; 97(6):763-772. PubMed ID: 36161330
[TBL] [Abstract][Full Text] [Related]
38. Pituitary tumors in patients with MEN1 syndrome.
Syro LV; Scheithauer BW; Kovacs K; Toledo RA; Londoño FJ; Ortiz LD; Rotondo F; Horvath E; Uribe H
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):43-8. PubMed ID: 22584705
[TBL] [Abstract][Full Text] [Related]
39. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.
Stratakis CA; Tichomirowa MA; Boikos S; Azevedo MF; Lodish M; Martari M; Verma S; Daly AF; Raygada M; Keil MF; Papademetriou J; Drori-Herishanu L; Horvath A; Tsang KM; Nesterova M; Franklin S; Vanbellinghen JF; Bours V; Salvatori R; Beckers A
Clin Genet; 2010 Nov; 78(5):457-63. PubMed ID: 20507346
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
